TR201004754A1 - Yeni Farmasötik Kombinasyonlar - Google Patents

Yeni Farmasötik Kombinasyonlar

Info

Publication number
TR201004754A1
TR201004754A1 TR2010/04754A TR201004754A TR201004754A1 TR 201004754 A1 TR201004754 A1 TR 201004754A1 TR 2010/04754 A TR2010/04754 A TR 2010/04754A TR 201004754 A TR201004754 A TR 201004754A TR 201004754 A1 TR201004754 A1 TR 201004754A1
Authority
TR
Turkey
Prior art keywords
pharmaceutical combinations
new pharmaceutical
derivatives
pharmaceutical composition
relates
Prior art date
Application number
TR2010/04754A
Other languages
English (en)
Inventor
T�Rkyilmaz Al�
Ramazano�Lu Gaye
Mutlu Onur
��Fter �M�T
Original Assignee
Sanovel �La� San. Ve T�C. A.�.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel �La� San. Ve T�C. A.�. filed Critical Sanovel �La� San. Ve T�C. A.�.
Priority to TR2010/04754A priority Critical patent/TR201004754A1/tr
Priority to DK11169599.5T priority patent/DK2394638T3/da
Priority to PT111695995T priority patent/PT2394638E/pt
Priority to ES11169599T priority patent/ES2424469T3/es
Priority to EP11169599.5A priority patent/EP2394638B1/en
Priority to PL13150074T priority patent/PL2586424T3/pl
Priority to ES13150074.6T priority patent/ES2522873T3/es
Priority to PL11169599T priority patent/PL2394638T3/pl
Priority to EP13150074.6A priority patent/EP2586424B1/en
Priority to US13/159,049 priority patent/US20110305757A1/en
Publication of TR201004754A1 publication Critical patent/TR201004754A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Mevcut buluş, yeni bir farmasötik bileşimle ilgili olup, etkin bileşen olarak Formül I (Bileşik I) ya da farmasötik olarak kabul edilebilir tuzlarını ve bır ya da birden fazla diüretik içerir, sozu edilen bır ya da birden fazla diüretik tiyazıd türevlen arasından seçilir Buluş ayrıca Bileşik I ve tiyazıd turevlerini içeren farmasötik bır bileşimin hazırlanmasında kullanılan yöntemlerle ve bu bileşimin memelilerde, ozellikle de insanlarda yüksek tansiyonun önlenmesi veya tedavisi ıçın kullanımıyla da ilgilidir.
TR2010/04754A 2010-06-11 2010-06-11 Yeni Farmasötik Kombinasyonlar TR201004754A1 (tr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
TR2010/04754A TR201004754A1 (tr) 2010-06-11 2010-06-11 Yeni Farmasötik Kombinasyonlar
DK11169599.5T DK2394638T3 (da) 2010-06-11 2011-06-10 Nye farmaceutiske sammensætninger
PT111695995T PT2394638E (pt) 2010-06-11 2011-06-10 Novas combinações farmacêuticas
ES11169599T ES2424469T3 (es) 2010-06-11 2011-06-10 Nuevas combinaciones farmacéuticas
EP11169599.5A EP2394638B1 (en) 2010-06-11 2011-06-10 New pharmaceutical combinations
PL13150074T PL2586424T3 (pl) 2010-06-11 2011-06-10 Kompozycje farmaceutyczne zawierające antagonistę receptora angiotensyny II, hydrochlorotiazyd i środek rozsadzający
ES13150074.6T ES2522873T3 (es) 2010-06-11 2011-06-10 Combinaciones farmacéuticas que contienen un antagonista de receptor de angiotensina II, hidroclorotiazida y un disgregante
PL11169599T PL2394638T3 (pl) 2010-06-11 2011-06-10 Nowe połączenia farmaceutyczne
EP13150074.6A EP2586424B1 (en) 2010-06-11 2011-06-10 Pharmaceutical combinations comprising an angiotensin II receptor antagonist, hydrochlorothiazide and a disintegrant.
US13/159,049 US20110305757A1 (en) 2010-06-11 2011-06-13 New pharmaceutical combinations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/04754A TR201004754A1 (tr) 2010-06-11 2010-06-11 Yeni Farmasötik Kombinasyonlar

Publications (1)

Publication Number Publication Date
TR201004754A1 true TR201004754A1 (tr) 2012-01-23

Family

ID=43303905

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/04754A TR201004754A1 (tr) 2010-06-11 2010-06-11 Yeni Farmasötik Kombinasyonlar

Country Status (7)

Country Link
US (1) US20110305757A1 (tr)
EP (2) EP2394638B1 (tr)
DK (1) DK2394638T3 (tr)
ES (2) ES2522873T3 (tr)
PL (2) PL2586424T3 (tr)
PT (1) PT2394638E (tr)
TR (1) TR201004754A1 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201007508A1 (tr) * 2010-09-14 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan bileşimler
KR101414873B1 (ko) * 2012-06-28 2014-07-03 보령제약 주식회사 피마살탄 및 히드로클로로티아지드가 함유된 약제학적 조성물
WO2014102628A1 (en) * 2012-12-31 2014-07-03 Ranbaxy Laboratories Limited Stable pharmaceutical composition comprising azilsartan medoxomil
EP3492466B1 (en) * 2016-07-29 2022-06-01 Wuhan LL Science And Technology Development Co., Ltd. Oral solid preparation and use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628313A1 (en) * 1993-06-07 1994-12-14 Takeda Chemical Industries, Ltd. Combination of benzimidazoles having angiotensin-II antagonistic activity with dinretics or calcium antagonists
WO1997002032A1 (en) * 1995-06-30 1997-01-23 Merck & Co., Inc. Method of treating renal disease using an ace inhibitor and an aii antagonist
WO2009115301A1 (en) * 2008-03-19 2009-09-24 Ratiopharm Gmbh Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2262484B1 (en) * 2008-03-11 2013-01-23 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
UY32126A (es) * 2008-09-25 2010-04-30 Takeda Pharmaceutical Composición farmacéutica sólida

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628313A1 (en) * 1993-06-07 1994-12-14 Takeda Chemical Industries, Ltd. Combination of benzimidazoles having angiotensin-II antagonistic activity with dinretics or calcium antagonists
WO1997002032A1 (en) * 1995-06-30 1997-01-23 Merck & Co., Inc. Method of treating renal disease using an ace inhibitor and an aii antagonist
WO2009115301A1 (en) * 2008-03-19 2009-09-24 Ratiopharm Gmbh Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHAH S U ET AL: "USE OF DIURETICS IN CARDIOVASCULAR DISEASE: (2) HYPERTENSION", POSTGRADUATE MEDICAL JOURNAL, MCMILLAN PRESS, BASINGSTOKE, GB, vol. 80, no. 943, 1 January 2004 (2004-01-01), pages 271 - 276, XP008040902, ISSN: 0032-5473, DOI: DOI:10.1136/PGMJ.2003.010843 *

Also Published As

Publication number Publication date
US20110305757A1 (en) 2011-12-15
EP2394638B1 (en) 2013-05-08
DK2394638T3 (da) 2013-07-15
EP2586424B1 (en) 2014-08-13
ES2522873T3 (es) 2014-11-18
ES2424469T3 (es) 2013-10-02
EP2586424A1 (en) 2013-05-01
EP2394638A1 (en) 2011-12-14
PL2394638T3 (pl) 2014-02-28
PL2586424T3 (pl) 2015-03-31
PT2394638E (pt) 2013-08-22

Similar Documents

Publication Publication Date Title
TR201904340T4 (tr) Yeni bileşikler.
EA201600366A1 (ru) Производные бензимидазол-пролина
GEP201606555B (en) Compounds and compositions for modulating egfr activity
CL2013000104A1 (es) Compuestos derivados de heterociclicos nitrogenados sustituidos, agonistas del receptor ip; composicion farmaceutica; combinación farmaceutica; y uso para el tratamiento de la hipertension arterial pulmonar.
CY1122182T1 (el) Ανοσοκατασταλτικες φαρμακοτεχνικες μορφες
EA201390885A1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
MA34069B1 (fr) Dérivés de n-(imidazopyrimidin-7-yl)hétéroarylamide et leur utilisation comme inhibiteurs de pde10a)
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
EA201990388A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
EA201100503A1 (ru) Глюкозидные производные и их применения
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
EA201591195A1 (ru) Новые хинолоновые производные
EA201290632A1 (ru) Производные бетулина
EA201270216A1 (ru) Фармацевтический состав
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
EA201071329A1 (ru) Диамидные производные адамантана и их применение
EA201692542A1 (ru) Индановые и индолиновые производные и их применение в качестве активаторов растворимой гуанилатциклазы
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA201170722A1 (ru) Лактамы в качестве ингибиторов бета-секретазы
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
EA201400822A1 (ru) Производные гетероциклических амидов в качестве антагонистов p2xрецептора